Pearson, Markus Stoffel and Anna L
FDA approval is expected in 2025-2026 if trials are successful
Q: How long will I need to take Semaglutide
Semaglutide is what is known as a GLP-1 receptor agonist, a class of medications that can slow down digestion, increase feelings of fullness, and reduce hunger
Queiroz ML, da Rocha MC, Torello CO, et al
The trial was designed to evaluate the effect in this population, over a period of up to five years, of a onceweekly subcutaneously administered dose of 2.4 mg semaglutide (Wegovy) on cardiovascular outcomes compared to placebo